Table 1.
Relationship between PKM2 expression and clinicopathological features in 345 CRC patients
| Variable | PKM2 (n) | ||
|---|---|---|---|
|
| |||
| Low n = 71 (%) | High n = 274 (%) | P | |
| Age | 0.692 | ||
| ≤ 65 years | 37 (19.8) | 150 (80.2) | |
| > 65 years | 34 (21.5) | 124 (78.5) | |
| Gender | 0.778 | ||
| Male | 42 (21.1) | 157 (78.9) | |
| Female | 29 (19.9) | 117 (80.1) | |
| Tumor size | 0.167 | ||
| ≤ 5 cm | 41 (23.6) | 133 (76.4) | |
| > 5 cm | 30 (17.5) | 141 (82.5) | |
| Tumor location | 0.334 | ||
| Rectum | 38 (18.8) | 164 (81.2) | |
| Colon | 33 (23.1) | 110 (76.9) | |
| Serum CEA | 0.000 | ||
| ≤ 5 ng/ml | 21 (11.6) | 160 (88.4) | |
| > 5 ng/ml | 50 (30.4) | 114 (69.6) | |
| Clinical stage | 0.003 | ||
| 0-I | 22 (25.9) | 63 (74.1) | |
| II | 33 (27.7) | 86 (72.3) | |
| III | 11 (9.4) | 106 (90.6) | |
| IV | 5 (20.8) | 19 (79.2) | |
| Histology | 0.967 | ||
| Mucinous | 11 (20.4) | 43 (79.6) | |
| Non-mucinous | 60 (20.6) | 231 (79.4) | |
The bold number represents the P-values with significantdifferences.